Cannon, MJ, Schmid, DS, Hyde, TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology
2010; 20: 202–213.
Manfredi, R, Calza, L, Chiodo, F. Primary cytomegalovirus infection in otherwise healthy adults with fever of unknown origin: a 3-year prospective survey. Infection
2006; 34: 87–90.
Dollard, SC, Grosse, SD, Ross, DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Reviews in Medical Virology
2007; 17: 355–367.
de Vries, JJC, et al.
The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Reviews in Medical Virology
2013; 23: 241–249.
Griffiths, PD. Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infectious Diseases
2012; 12: 790–798.
Modlin, JF, et al.
Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clinical Infectious Diseases
2004; 39: 233–239.
Hyde, TB, Schmid, DS, Cannon, MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Reviews in Medical Virology
2010; 20: 311–326.
Stadler, LP, et al.
Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males. Clinical Infectious Diseases
2010; 51: e76–e81.
Sohn, YM, et al.
Cytomegalovirus infection in sexually active adolescents. Journal of Infectious Diseases
1991; 163: 460–463.
Stanberry, LR, et al.
Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clinical Infectious Diseases
2004; 39: 1433–1438.
B Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. Journal of Infectious Diseases
1999; 180: 702–707.
Crawford, DH, et al.
A cohort study among university students: identification of risk factors for Epstein–Barr virus seroconversion and infectious mononucleosis. Clinical Infectious Diseases
2006; 43: 276–282.
Staras, SA, et al.
Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988–1994. Sexually Transmitted Diseases
2008; 35: 472–479.
Hecker, M, et al.
Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sanguinis
2004; 86: 41–44.